BRIAN P MCKEON Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for BRIAN P MCKEON.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of BRIAN P MCKEON. BRIAN P MCKEON is EVP, CFO & Treasurer in IDEXX LABORATORIES INC /DE ($IDXX) and EVP, CFO and Treasurer in IDEXX LABORATORIES INC /DE ($IDXX) and EVP, CFO, and Treasurer in IDEXX LABORATORIES INC /DE ($IDXX) and Executive VP & CFO in IDEXX LABORATORIES INC /DE ($IDXX) and See Remarks in IDEXX LABORATORIES INC /DE ($IDXX) and Director in ATHENAHEALTH INC ($ATHN) and Director in Alkermes plc. ($ALKS).
Latest Insider Trading Transactions of BRIAN P MCKEON
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ALKS, ATHN, IDXX
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 19 2021 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Option Exercise | M | 67.85 | 1,474 | 100,011 | 0 | |
| Feb 19 2021 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Buy | M | 67.85 | 1,474 | 100,011 | 26,188 | 24.7 K to 26.2 K (+5.96 %) |
| Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Option Exercise | M | 0.00 | 433 | 0 | 5,850 | |
| Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Option Exercise | M | 0.00 | 435 | 0 | 6,283 | |
| Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Option Exercise | M | 0.00 | 505 | 0 | 6,718 | |
| Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Option Exercise | M | 0.00 | 459 | 0 | 7,223 | |
| Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Option Exercise | M | 0.00 | 810 | 0 | 7,682 | |
| Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Option Exercise | A | 0.00 | 1,011 | 0 | 8,492 | |
| Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Option Exercise | A | 544.08 | 183 | 99,567 | 183 | |
| Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Option Exercise | A | 544.08 | 9,538 | 5,189,435 | 9,538 | |
| Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Sell | S | 539.58 | 1,307 | 705,231 | 24,714 | 26 K to 24.7 K (-5.02 %) |
| Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Payment of Exercise | F | 544.08 | 1,335 | 726,347 | 26,021 | 27.4 K to 26 K (-4.88 %) |
| Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Buy | M | 0.00 | 433 | 0 | 27,356 | 26.9 K to 27.4 K (+1.61 %) |
| Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Buy | M | 0.00 | 435 | 0 | 26,923 | 26.5 K to 26.9 K (+1.64 %) |
| Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Buy | M | 0.00 | 505 | 0 | 26,488 | 26 K to 26.5 K (+1.94 %) |
| Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Buy | M | 0.00 | 459 | 0 | 25,983 | 25.5 K to 26 K (+1.80 %) |
| Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Buy | M | 0.00 | 810 | 0 | 25,524 | 24.7 K to 25.5 K (+3.28 %) |
| Feb 11 2021 | ALKS | Alkermes plc. | MCKEON BRIAN P | Director | Option Exercise | A | 0.00 | 2,223 | 0 | 2,223 | |
| Feb 11 2021 | ALKS | Alkermes plc. | MCKEON BRIAN P | Director | Option Exercise | A | 22.93 | 4,549 | 104,309 | 4,549 | |
| Feb 11 2021 | ALKS | Alkermes plc. | MCKEON BRIAN P | Director | Option Exercise | A | 0.00 | 13,336 | 0 | 13,336 | |
| Feb 11 2021 | ALKS | Alkermes plc. | MCKEON BRIAN P | Director | Option Exercise | A | 22.93 | 26,169 | 600,055 | 26,169 | |
| Nov 10 2020 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Sell | S | 478.13 | 3,000 | 1,434,380 | 18,050 | 21.1 K to 18.1 K (-14.25 %) |
| Nov 10 2020 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Sell | S | 476.89 | 2,100 | 1,001,466 | 21,050 | 23.2 K to 21.1 K (-9.07 %) |
| Nov 10 2020 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Sell | S | 475.50 | 300 | 142,650 | 23,150 | 23.5 K to 23.2 K (-1.28 %) |
| Nov 10 2020 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Sell | S | 475.02 | 3,338 | 1,585,625 | 23,450 | 26.8 K to 23.5 K (-12.46 %) |
| Nov 10 2020 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Sell | S | 474.14 | 1,241 | 588,404 | 26,788 | 28 K to 26.8 K (-4.43 %) |
| Nov 10 2020 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Sell | S | 472.88 | 21 | 9,931 | 28,029 | 28.1 K to 28 K (-0.07 %) |
| Nov 06 2020 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Option Exercise | M | 79.54 | 36,216 | 2,880,621 | 0 | |
| Nov 06 2020 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Sell | S | 481.26 | 200 | 96,252 | 24,700 | 24.9 K to 24.7 K (-0.80 %) |
| Nov 06 2020 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Sell | S | 480.31 | 566 | 271,854 | 24,900 | 25.5 K to 24.9 K (-2.22 %) |
| Nov 06 2020 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Sell | S | 479.69 | 1,534 | 735,851 | 25,466 | 27 K to 25.5 K (-5.68 %) |
| Nov 06 2020 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Sell | S | 477.02 | 390 | 186,036 | 27,000 | 27.4 K to 27 K (-1.42 %) |
| Nov 06 2020 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Sell | S | 476.01 | 3,596 | 1,711,740 | 27,390 | 31 K to 27.4 K (-11.61 %) |
| Nov 06 2020 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Sell | S | 475.20 | 3,474 | 1,650,846 | 30,986 | 34.5 K to 31 K (-10.08 %) |
| Nov 06 2020 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Sell | S | 473.97 | 244 | 115,648 | 34,460 | 34.7 K to 34.5 K (-0.70 %) |
| Nov 06 2020 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Sell | S | 473.04 | 2,407 | 1,138,602 | 34,704 | 37.1 K to 34.7 K (-6.49 %) |
| Nov 06 2020 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Sell | S | 472.20 | 1,107 | 522,721 | 37,111 | 38.2 K to 37.1 K (-2.90 %) |
| Nov 06 2020 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Sell | S | 471.02 | 2,493 | 1,174,259 | 38,218 | 40.7 K to 38.2 K (-6.12 %) |
| Nov 06 2020 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Sell | S | 469.80 | 2,850 | 1,338,921 | 40,711 | 43.6 K to 40.7 K (-6.54 %) |
| Nov 06 2020 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Sell | S | 469.09 | 9,617 | 4,511,281 | 43,561 | 53.2 K to 43.6 K (-18.08 %) |
| Nov 06 2020 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Sell | S | 467.97 | 6,338 | 2,965,970 | 53,178 | 59.5 K to 53.2 K (-10.65 %) |
| Nov 06 2020 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Sell | S | 467.01 | 1,400 | 653,820 | 59,516 | 60.9 K to 59.5 K (-2.30 %) |
| Nov 06 2020 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Buy | M | 79.54 | 36,216 | 2,880,621 | 60,916 | 24.7 K to 60.9 K (+146.62 %) |
| Aug 20 2020 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Option Exercise | M | 79.54 | 1,256 | 99,902 | 0 | |
| Aug 20 2020 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Option Exercise | M | 53.19 | 1,880 | 99,988 | 0 | |
| Aug 20 2020 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Buy | M | 79.54 | 1,256 | 99,902 | 52,732 | 51.5 K to 52.7 K (+2.44 %) |
| Aug 20 2020 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Buy | M | 53.19 | 1,880 | 99,988 | 51,486 | 49.6 K to 51.5 K (+3.79 %) |
| Aug 18 2020 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Option Exercise | M | 62.00 | 37,098 | 2,300,076 | 0 | |
| Aug 18 2020 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Option Exercise | M | 53.19 | 37,836 | 2,012,308 | 0 | |
| Aug 18 2020 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Option Exercise | M | 43.68 | 8,790 | 383,947 | 0 | |
| Aug 18 2020 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Sell | S | 381.48 | 3,049 | 1,163,118 | 49,596 | 52.6 K to 49.6 K (-5.79 %) |
| Aug 18 2020 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Sell | S | 380.12 | 14,469 | 5,499,962 | 52,645 | 67.1 K to 52.6 K (-21.56 %) |
| Aug 18 2020 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Sell | S | 379.20 | 37,209 | 14,109,701 | 67,114 | 104.3 K to 67.1 K (-35.67 %) |
| Aug 18 2020 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Sell | S | 377.84 | 28,997 | 10,956,290 | 104,323 | 133.3 K to 104.3 K (-21.75 %) |
| Aug 18 2020 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Buy | M | 62.00 | 37,098 | 2,300,076 | 133,320 | 96.2 K to 133.3 K (+38.55 %) |
| Aug 18 2020 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Buy | M | 53.19 | 37,836 | 2,012,308 | 96,222 | 58.4 K to 96.2 K (+64.80 %) |
| Aug 18 2020 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Buy | M | 43.68 | 8,790 | 383,947 | 58,386 | 49.6 K to 58.4 K (+17.72 %) |
| Aug 07 2020 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | EVP, CFO & Treasure ... | Option Exercise | M | 0.00 | 193 | 0 | 7,481 | |
| Aug 07 2020 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | EVP, CFO & Treasure ... | Payment of Exercise | F | 395.71 | 97 | 38,384 | 49,596 | 49.7 K to 49.6 K (-0.20 %) |
| Aug 07 2020 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | EVP, CFO & Treasure ... | Buy | M | 0.00 | 193 | 0 | 49,693 | 49.5 K to 49.7 K (+0.39 %) |
| Feb 19 2020 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Option Exercise | M | 0.00 | 435 | 0 | 7,674 | |
| Feb 19 2020 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Option Exercise | M | 0.00 | 505 | 0 | 8,109 | |
| Feb 19 2020 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Option Exercise | M | 0.00 | 459 | 0 | 8,614 | |
| Feb 19 2020 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Option Exercise | M | 0.00 | 810 | 0 | 9,073 | |
| Feb 19 2020 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Option Exercise | M | 0.00 | 628 | 0 | 9,883 | |
| Feb 19 2020 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Option Exercise | A | 0.00 | 1,731 | 0 | 10,511 | |
| Feb 19 2020 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Option Exercise | A | 288.78 | 17,813 | 5,144,038 | 17,813 | |
| Feb 19 2020 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Payment of Exercise | F | 288.78 | 979 | 282,716 | 49,457 | 50.4 K to 49.5 K (-1.94 %) |
| Feb 19 2020 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Buy | M | 0.00 | 435 | 0 | 50,436 | 50 K to 50.4 K (+0.87 %) |
| Feb 19 2020 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Buy | M | 0.00 | 505 | 0 | 50,001 | 49.5 K to 50 K (+1.02 %) |
| Feb 19 2020 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Buy | M | 0.00 | 459 | 0 | 49,496 | 49 K to 49.5 K (+0.94 %) |
| Feb 19 2020 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Buy | M | 0.00 | 810 | 0 | 49,037 | 48.2 K to 49 K (+1.68 %) |
| Feb 19 2020 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Buy | M | 0.00 | 628 | 0 | 48,227 | 47.6 K to 48.2 K (+1.32 %) |
| Aug 07 2019 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Option Exercise | A | 0.00 | 961 | 0 | 8,780 | |
| Aug 07 2019 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Option Exercise | A | 260.07 | 10,058 | 2,615,784 | 0 | |
| May 06 2019 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Option Exercise | M | 44.05 | 7,504 | 330,514 | 0 | |
| May 06 2019 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Sell | S | 248.79 | 629 | 156,492 | 47,528 | 48.2 K to 47.5 K (-1.31 %) |
| May 06 2019 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Sell | S | 248.28 | 5,771 | 1,432,819 | 48,157 | 53.9 K to 48.2 K (-10.70 %) |
| May 06 2019 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Sell | S | 247.28 | 225 | 55,638 | 53,928 | 54.2 K to 53.9 K (-0.42 %) |
| May 06 2019 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Sell | S | 245.77 | 375 | 92,165 | 54,153 | 54.5 K to 54.2 K (-0.69 %) |
| May 06 2019 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Sell | S | 244.57 | 300 | 73,372 | 54,528 | 54.8 K to 54.5 K (-0.55 %) |
| May 06 2019 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Sell | S | 242.72 | 204 | 49,514 | 54,828 | 55 K to 54.8 K (-0.37 %) |
| May 06 2019 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Buy | M | 44.05 | 7,504 | 330,514 | 55,032 | 47.5 K to 55 K (+15.79 %) |
| Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Option Exercise | M | 0.00 | 505 | 0 | 7,819 | |
| Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Option Exercise | M | 0.00 | 459 | 0 | 8,324 | |
| Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Option Exercise | M | 0.00 | 811 | 0 | 8,783 | |
| Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Option Exercise | M | 0.00 | 629 | 0 | 9,594 | |
| Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Option Exercise | M | 0.00 | 726 | 0 | 10,223 | |
| Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Option Exercise | M | 0.00 | 2,175 | 0 | 10,949 | |
| Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Option Exercise | M | 206.94 | 483 | 99,952 | 483 | |
| Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Option Exercise | M | 206.94 | 20,753 | 4,294,626 | 20,753 | |
| Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Payment of Exercise | F | 206.94 | 1,612 | 333,587 | 47,496 | 49.1 K to 47.5 K (-3.28 %) |
| Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Buy | M | 0.00 | 505 | 0 | 49,108 | 48.6 K to 49.1 K (+1.04 %) |
| Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Buy | M | 0.00 | 459 | 0 | 48,603 | 48.1 K to 48.6 K (+0.95 %) |
| Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Buy | M | 0.00 | 811 | 0 | 48,144 | 47.3 K to 48.1 K (+1.71 %) |
| Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Buy | M | 0.00 | 629 | 0 | 47,333 | 46.7 K to 47.3 K (+1.35 %) |
| Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Buy | M | 0.00 | 726 | 0 | 46,704 | 46 K to 46.7 K (+1.58 %) |
| Feb 13 2019 | ATHN | ATHENAHEALTH INC | MCKEON BRIAN P | Director | Sell | D | 135.00 | 2,721 | 367,335 | 0 | 2.7 K to 0 (-100.00 %) |
| Jan 03 2019 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Option Exercise | M | 0.00 | 2,820 | 0 | 8,774 | |
| Jan 03 2019 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Payment of Exercise | F | 186.02 | 1,006 | 187,136 | 45,978 | 47 K to 46 K (-2.14 %) |
| Jan 03 2019 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Buy | M | 0.00 | 2,820 | 0 | 48,984 | 46.2 K to 49 K (+6.11 %) |
| Jun 08 2018 | ATHN | ATHENAHEALTH INC | MCKEON BRIAN P | Director | Grant | A | 0.00 | 1,931 | 0 | 2,721 | 790 to 2.7 K (+244.43 %) |
| Feb 16 2018 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Option Exercise | M | 0.00 | 459 | 0 | 11,594 | |
| Feb 16 2018 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Option Exercise | M | 0.00 | 811 | 0 | 12,053 | |
| Feb 16 2018 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Option Exercise | M | 0.00 | 629 | 0 | 12,864 | |
| Feb 16 2018 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Option Exercise | M | 0.00 | 726 | 0 | 13,493 | |
| Feb 16 2018 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Option Exercise | A | 0.00 | 2,524 | 0 | 14,219 | |
| Feb 16 2018 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Option Exercise | A | 178.26 | 560 | 99,826 | 560 | |
| Feb 16 2018 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Option Exercise | A | 178.26 | 25,140 | 4,481,456 | 25,140 | |
| Feb 16 2018 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Payment of Exercise | F | 178.26 | 903 | 160,969 | 44,040 | 44.9 K to 44 K (-2.01 %) |
| Feb 16 2018 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Buy | M | 0.00 | 459 | 0 | 44,943 | 44.5 K to 44.9 K (+1.03 %) |
| Feb 16 2018 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Buy | M | 0.00 | 811 | 0 | 44,484 | 43.7 K to 44.5 K (+1.86 %) |
| Feb 16 2018 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Buy | M | 0.00 | 629 | 0 | 43,673 | 43 K to 43.7 K (+1.46 %) |
| Feb 16 2018 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Buy | M | 0.00 | 726 | 0 | 43,044 | 42.3 K to 43 K (+1.72 %) |
| Feb 07 2018 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Option Exercise | M | 38.80 | 6,602 | 256,125 | 0 | |
| Feb 07 2018 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Sell | S | 182.33 | 1,200 | 218,792 | 40,438 | 41.6 K to 40.4 K (-2.88 %) |
| Feb 07 2018 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Sell | S | 181.44 | 3,706 | 672,406 | 41,638 | 45.3 K to 41.6 K (-8.17 %) |
| Feb 07 2018 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Sell | S | 180.53 | 1,696 | 306,171 | 45,344 | 47 K to 45.3 K (-3.61 %) |
| Feb 07 2018 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Buy | M | 38.80 | 6,602 | 256,125 | 47,040 | 40.4 K to 47 K (+16.33 %) |
| Sep 06 2017 | ATHN | ATHENAHEALTH INC | MCKEON BRIAN P | Director | Grant | A | 0.00 | 790 | 0 | 790 | 0 to 790 |
| Feb 21 2017 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Option Exercise | M | 53.19 | 1,880 | 99,988 | 3,760 | |
| Feb 21 2017 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Buy | M | 53.19 | 1,880 | 99,988 | 38,548 | 36.7 K to 38.5 K (+5.13 %) |
| Feb 16 2017 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Option Exercise | M | 0.00 | 811 | 0 | 14,515 | |
| Feb 16 2017 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Option Exercise | M | 0.00 | 629 | 0 | 15,326 | |
| Feb 16 2017 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Option Exercise | M | 0.00 | 726 | 0 | 15,955 | |
| Feb 16 2017 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Option Exercise | A | 0.00 | 2,295 | 0 | 16,681 | |
| Feb 16 2017 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Option Exercise | A | 141.60 | 706 | 99,970 | 706 | |
| Feb 16 2017 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Option Exercise | A | 141.60 | 23,326 | 3,302,962 | 23,326 | |
| Feb 16 2017 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Payment of Exercise | F | 141.60 | 809 | 114,554 | 36,668 | 37.5 K to 36.7 K (-2.16 %) |
| Feb 16 2017 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Buy | M | 0.00 | 811 | 0 | 37,477 | 36.7 K to 37.5 K (+2.21 %) |
| Feb 16 2017 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Buy | M | 0.00 | 629 | 0 | 36,666 | 36 K to 36.7 K (+1.75 %) |
| Feb 16 2017 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Buy | M | 0.00 | 726 | 0 | 36,037 | 35.3 K to 36 K (+2.06 %) |
| Feb 09 2017 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Option Exercise | M | 26.66 | 9,924 | 264,524 | 0 | |
| Feb 09 2017 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Sell | S | 142.24 | 970 | 137,971 | 35,311 | 36.3 K to 35.3 K (-2.67 %) |
| Feb 09 2017 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Sell | S | 141.57 | 8,954 | 1,267,620 | 36,281 | 45.2 K to 36.3 K (-19.79 %) |
| Feb 09 2017 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Buy | M | 26.66 | 9,924 | 264,524 | 45,235 | 35.3 K to 45.2 K (+28.10 %) |
| Jan 04 2017 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Option Exercise | M | 0.00 | 2,820 | 0 | 14,386 | |
| Jan 04 2017 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Payment of Exercise | F | 117.27 | 1,105 | 129,583 | 35,311 | 36.4 K to 35.3 K (-3.03 %) |
| Jan 04 2017 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Buy | M | 0.00 | 2,820 | 0 | 36,416 | 33.6 K to 36.4 K (+8.39 %) |
| Feb 17 2016 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | See Remarks | Option Exercise | M | 0.00 | 629 | 0 | 17,206 | |
| Feb 17 2016 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | See Remarks | Option Exercise | M | 0.00 | 726 | 0 | 17,835 | |
| Feb 17 2016 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | See Remarks | Option Exercise | A | 0.00 | 4,053 | 0 | 18,561 | |
| Feb 17 2016 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | See Remarks | Option Exercise | A | 67.85 | 1,474 | 100,011 | 1,474 | |
| Feb 17 2016 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | See Remarks | Option Exercise | A | 67.85 | 35,535 | 2,411,050 | 45,535 | |
| Feb 17 2016 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | See Remarks | Payment of Exercise | F | 67.85 | 505 | 34,264 | 33,331 | 33.8 K to 33.3 K (-1.49 %) |
| Feb 17 2016 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | See Remarks | Buy | M | 0.00 | 629 | 0 | 33,816 | 33.2 K to 33.8 K (+1.90 %) |
| Feb 17 2016 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | See Remarks | Buy | M | 0.00 | 726 | 0 | 33,187 | 32.5 K to 33.2 K (+2.24 %) |
| Feb 09 2016 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | EVP, CFO and Treasu ... | Option Exercise | M | 17.19 | 9,054 | 155,593 | 0 | |
| Feb 09 2016 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | EVP, CFO and Treasu ... | Option Exercise | M | 53.19 | 1,880 | 99,988 | 5,640 | |
| Feb 09 2016 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | EVP, CFO and Treasu ... | Sell | S | 70.06 | 4,854 | 340,080 | 32,461 | 37.3 K to 32.5 K (-13.01 %) |